Candida and Candidiasis Conference 2023

2023 年念珠菌和念珠菌病会议

基本信息

批准号：
10682982
负责人：
Richard John Bennett
金额：
$ 0.7万
依托单位：
BROWN UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-03-08 至 2024-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10682982
关键词：
Address Affect Agreement American Antifungal Agents Area Biological Biology Blood Circulation COVID-19 pandemic CRISPR/Cas technology Canada Candida Candida albicans Candida auris Candidiasis Cell Communication Cessation of life Clinic Clinical Clinical Treatment Collaborations Communities Consensus DNA cassette Development Diagnosis Disease Drug resistance Elevator Epidemiology Event Faculty Feedback Female Fostering Funding Gene Deletion Genetic Genomics Goals Human Hybrids Immune response Immunology Infection Inflammation Interdisciplinary Study International Invaded Life Medical Methodology Microbiology Modeling Mouth Diseases Mucous Membrane Multi-Drug Resistance Mycoses Oral Oral candidiasis Participant Persons Play Positioning Attribute Postdoctoral Fellow Proteomics Publications Quebec Recording of previous events Reporting Research Research Personnel Role Running San Francisco Schedule Scientist Seminal Sexual Reproduction Societies Speed Structure Students Surveys Systemic infection Systems Biology Technology The science of Mycology Therapeutic Thinking Time Tissues Toxin Underrepresented Minority Work candidemia career career development cost design drug development emerging pathogen experience graduate student interest meetings member microbiome next generation novel therapeutic intervention pathogen pathogenic fungus posters professor programs research and development scientific organization success symposium tool transcriptomics translational scientist vaginal candidiasis virtual

项目摘要

Project Summary Fungal infections affect more than a billion people each year, of which 150 million cases are severe or life- threatening infections that result in 1.7 million deaths. Candida species are the major cause of life- threatening fungal disease in nosocomial settings, and cause a wide variety of diseases from oral and vaginal candidiasis to bloodstream candidemia. Research into Candida biology addresses a broad spectrum of topics relating to epidemiology, drug resistance, host response, and therapeutics. The Candida and Candidiasis Conference has been held every two to three years since 1987. This conference is the premier forum for the Candida community to assemble and to discuss the latest research in all areas of Candida biology, including emerging species of concern such as the multidrug resistant species Candida auris. Funds are requested for support towards for the 2023 Candida and Candidiasis conference to be held May 13-17 at the Le Centre Sheraton hotel in Montreal, Canada. This meeting will be run with the support of the Microbiological Society who are experienced with the organizing of scientific conferences. It is envisaged that 300-350 U.S. and international scientists will attend this meeting in person, and the conference has received enthusiastic support from the community and from past surveys of participants. The 2023 iteration of the conference is particularly important given that the 2020 conference was cancelled and held remotely (only) in 2021. The Program includes 8 main sessions with 6 speakers in each, as well as 3 parallel sessions and 2 elevator sessions. These sessions are designed to provide as much opportunity as possible for junior investigators (students, postdocs and junior professors) to give oral presentations to the community. At least 60 of the talks for the main and parallel sessions will be selected based on submitted abstracts. Elevator sessions will allow a further 37 junior scientists to summarize their research in short talks on the main stage. There will also be three poster sessions will allow discussion of the expected 200-300 posters. The main talks will also be recorded and made available online for those unable to attend the conference in person, which will expand the accessibility of the meeting worldwide. Clinical sessions are also a key part of the meeting as the conference seeks to foster interactions between basic and translational researchers. These sessions will bring the community up to speed in the challenges of diagnosing and treating Candida infections in nosocomial settings. The Candida and Candidiasis meeting has a strong track record of inclusion, with 50% of the session chairs being female while we also encourage and support attendance from underrepresented minorities. We are confident that the conference will promote synergistic and interdisciplinary interactions between all members of the research community, and will drive research into Candida biology and help develop new therapeutic approaches.

项目概要真菌感染每年影响超过十亿人，其中 1.5 亿病例为重症或危及生命威胁感染，导致 170 万人死亡。念珠菌属是生命的主要原因在医院环境中具有威胁性的真菌病，并引起口腔和口腔等多种疾病阴道念珠菌病转为血流念珠菌血症。对念珠菌生物学的研究涉及广泛与流行病学、耐药性、宿主反应和治疗学相关的一系列主题。自 1987 年以来，念珠菌和念珠菌病会议每两到三年举行一次。会议是念珠菌社区聚集和讨论最新研究的首要论坛念珠菌生物学的所有领域，包括新出现的令人关注的物种，例如多重耐药菌种耳念珠菌。请求资金支持 2023 年念珠菌和念珠菌病会议将于 5 月 13 日至 17 日在加拿大蒙特利尔的 Le Centre Sheraton 酒店举行。这次会议将是在微生物学会的支持下运行，微生物学会在组织科学活动方面经验丰富会议。预计将有 300-350 名美国和国际科学家参加这次会议人，并且会议得到了社区和过去的调查的热情支持参与者。鉴于 2020 年会议 2021 年被取消并（仅）远程举行。该计划包括 8 个主会议，每个会议有 6 名发言人，以及 3 个平行会议和 2 个平行会议。电梯会议。这些课程旨在为初级学生提供尽可能多的机会研究人员（学生、博士后和初级教授）向社区进行口头报告。在根据提交的摘要，将选出至少 60 个主会场和分会场的演讲。电梯会议将允许另外 37 名初级科学家通过简短的演讲总结他们的研究主舞台。还将举行三场海报会议，对预计 200-300 张海报进行讨论。主要演讲也将被录制并在线提供给那些无法参加会议的人人，这将扩大会议在全球范围内的可及性。临床会议也是会议的重要组成部分，因为会议旨在促进之间的互动基础和转化研究人员。这些会议将使社区能够快速应对挑战在医院环境中诊断和治疗念珠菌感染。念珠菌和念珠菌病会议拥有良好的包容性记录，50% 的会议主席是女性，而我们也鼓励和支持代表性不足的少数群体的出席。我们对此次会议充满信心将促进研究界所有成员之间的协同和跨学科互动，并将推动念珠菌生物学研究并帮助开发新的治疗方法。